Antitrypanosomal therapy for Chagas disease: A single center experience with adverse drug reactions and strategies for enhancing treatment completion.

Anti-trypanosomal therapy is generally recommended for individuals under age 50 with the indeterminate form of Chagas disease to prevent disease progression. However, benznidazole and nifurtimox are associated with adverse drug reactions. We performed a retrospective review of treatment tolerability...

Ful tanımlama

Kaydedildi:

Detaylı Bibliyografya
Asıl Yazarlar:	Katherine Reifler, Alyse Wheelock, Samantha M Hall, Madolyn Dauphinais, Samuel Roytburd, Michael Maiullari, Alejandra Salazar, Ashley Maldonado, Helen Mahoney West, Julia R Köhler, Elizabeth D Barnett, Deepa M Gopal, Davidson H Hamer, Daniel L Bourque
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	Public Library of Science (PLoS) 2025-07-01
Seri Bilgileri:	PLoS Neglected Tropical Diseases
Online Erişim:	https://doi.org/10.1371/journal.pntd.0013218
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Antitrypanosomal therapy for Chagas disease: A single center experience with adverse drug reactions and strategies for enhancing treatment completion.

Benzer Materyaller